← All Sponsors
SPONSOR

University of East Anglia

Total Trials
1
Recruiting
1
Phases
Phase 2, Phase 3
Conditions studied: Embolic Stroke of Undetermined SourceAtrial Fibrillation New Onset
NCT06715449 Phase 2, Phase 3
Recruiting

EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source

Embolic Stroke of Undetermined Source
United Kingdom View Trial →